HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janus kinase signaling activation mediates peritoneal inflammation and injury in vitro and in vivo in response to dialysate.

Abstract
Peritoneal membrane pathology limits long-term peritoneal dialysis (PD). Here, we tested whether JAK/STAT signaling is implicated and if its attenuation might be salutary. In cultured mesothelial cells, PD fluid activated, and the pan-JAK inhibitor P6 reduced, phospho-STAT1 and phospho-STAT3, periostin secretion, and cleaved caspase-3. Ex vivo, JAK was phosphorylated in PD effluent cells from long-term but not new PD patients. MCP-1 and periostin were increased in PD effluent in long term compared with new patients. In rats, twice daily, PD fluid infusion induced phospho-JAK, mesothelial cell hyperplasia, inflammation, fibrosis, and hypervascularity after 10 days of exposure to PD fluid. Concomitant instillation of a JAK1/2 inhibitor virtually completely attenuated these changes. Thus, our studies directly implicate JAK/STAT signaling in the mediation of peritoneal membrane pathology as a consequence of PD.
AuthorsTiane Dai, Ying Wang, Aditi Nayak, Cynthia C Nast, Lan Quang, Janine LaPage, Ali Andalibi, Sharon G Adler
JournalKidney international (Kidney Int) Vol. 86 Issue 6 Pg. 1187-96 (Dec 2014) ISSN: 1523-1755 [Electronic] United States
PMID25007168 (Publication Type: Journal Article)
Chemical References
  • CCL2 protein, human
  • Ccl2 protein, rat
  • Cell Adhesion Molecules
  • Chemokine CCL2
  • Dialysis Solutions
  • Nitriles
  • POSTN protein, human
  • Postn protein, rat
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • ruxolitinib
  • Janus Kinases
  • Caspase 3
Topics
  • Animals
  • Caspase 3 (metabolism)
  • Cell Adhesion Molecules (metabolism)
  • Cells, Cultured
  • Chemokine CCL2 (metabolism)
  • Dialysis Solutions (adverse effects)
  • Epithelial Cells
  • Female
  • Humans
  • Hyperplasia (chemically induced)
  • Janus Kinases (antagonists & inhibitors, metabolism)
  • Male
  • Neovascularization, Pathologic (chemically induced)
  • Nitriles
  • Peritoneal Dialysis (adverse effects)
  • Peritoneal Fibrosis (chemically induced)
  • Peritoneum (blood supply, pathology)
  • Peritonitis (chemically induced, metabolism)
  • Phosphorylation
  • Protein Kinase Inhibitors (pharmacology)
  • Pyrazoles (pharmacology)
  • Pyrimidines
  • Rats
  • STAT1 Transcription Factor (metabolism)
  • STAT3 Transcription Factor (metabolism)
  • Signal Transduction (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: